NCT05311813View on ClinicalTrials.gov

Safety and Efficacy of Enoxaparin and Hydroxychloroquine in COVID-19

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 1, 2021

Study Completion Date

December 30, 2021

Conditions
COVID-19 Pandemic
Interventions
DRUG

Enoxaparin, Hydroxychloroquine

To compare efficiency and safety of Enoxaparin and Hydroxychloroquine as monotherapy versus Polytherapy

Trial Locations (1)

62511

Beni-Suef University teaching Hospital, Banī Suwayf

All Listed Sponsors
lead

Beni-Suef University

OTHER